Susceptibility of common aerobic pathogens to tigecycline: results of a surveillance study in Germany

[1]  W. Witte,et al.  Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient. , 2008, The Journal of antimicrobial chemotherapy.

[2]  N. Woodford,et al.  In vitro activity of tigecycline against carbapenem-susceptible and -resistant isolates of Klebsiella spp. and Enterobacter spp. , 2007, The Journal of antimicrobial chemotherapy.

[3]  M. Kresken,et al.  Drug resistance among clinical isolates of frequently encountered bacterial species in central Europe during 1975–1995 , 2007, Infection.

[4]  A. MacGowan,et al.  EUCAST technical note on tigecycline. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  K. Waites,et al.  Antimicrobial Susceptibility among Pathogens Collected from Hospitalized Patients in the United States and In Vitro Activity of Tigecycline, a New Glycylcycline Antimicrobial , 2006, Antimicrobial Agents and Chemotherapy.

[6]  D. Livermore.  Tigecycline: what is it, and where should it be used? , 2005, The Journal of antimicrobial chemotherapy.

[7]  P. Bradford,et al.  In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  D. Hoban,et al.  In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004) , 2005 .

[9]  J. Verhoef,et al.  Presence of Tetracycline Resistance Determinants and Susceptibility to Tigecycline and Minocycline , 2005, Antimicrobial Agents and Chemotherapy.

[10]  D. Hoban,et al.  In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004). , 2005, Diagnostic microbiology and infectious disease.

[11]  N. Jacobus,et al.  In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9-t-Butylglycylamido Derivative of Minocycline (GAR-936) , 1999, Antimicrobial Agents and Chemotherapy.